Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario de la Princesa (39)

2023

  1. Do Elderly Patients with Heart Failure and Reduced Ejection Fraction Benefit from Pharmacological Strategies for Prevention of Arrhythmic Events?

    Cardiology, Vol. 148, Núm. 3, pp. 195-206

  2. Do Women Physicians Accept and Follow Heart Failure Guidelines More Than Men?

    Current Heart Failure Reports, Vol. 20, Núm. 3, pp. 151-156

  3. Opinion on the 2021 ESC guidelines on heart failure: a cross-sectional survey of 387 doctors

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 7-15

2022

  1. Frailty and prognosis of older patients with chronic heart failure

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1011-1019

  2. Impact of blood pressure on management and prognosis of patients treated with sacubitril/valsartan

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 116-122

2021

  1. Initiation and titration of sacubitril/valsartan in different types of centers

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97

2020

  1. Functional heterogeneity of mouse and human brain opcs: Relevance for preclinical studies in multiple sclerosis

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-21

  2. Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 145, Núm. 5, pp. 275-282

  3. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

  4. Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 2, pp. 65-69

  5. Selection of the best of 2019 in geriatric cardiology

    REC: CardioClinics, Vol. 55, pp. 3-9

2019

  1. Influence of a Serratia marcescens outbreak on the gut microbiota establishment process in low-weight preterm neonates

    PLoS ONE, Vol. 14, Núm. 5

  2. Safety of sacubitril/valsartan initiated during hospitalization: data from a non-selected cohort

    ESC Heart Failure, Vol. 6, Núm. 6, pp. 1161-1166

  3. Selection of the best of 2018 in geriatric cardiology

    REC: CardioClinics, Vol. 54, pp. 10-15

  4. Sex Influence on the Efficacy and Safety of Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 142, Núm. 2, pp. 73-78

2018

  1. Clinical Profile of a Nonselected Population Treated With Sacubitril/Valsartan Is Different From PARADIGM-HF Trial

    Journal of cardiovascular pharmacology, Vol. 72, Núm. 2, pp. 112-116

  2. Higher proportion of non-1-84 PTH fragments in peritoneal dialysis patients compared to hemodialysis patients using solutions containing 1.75 mmol/l calcium

    Frontiers in Physiology, Vol. 9, Núm. NOV

  3. Microbiota and Human Health: characterization techniques and transference

    Enfermedades Infecciosas y Microbiologia Clinica

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5